Management of antithrombotic therapy in patients undergoing dental procedures
Journal of Thrombosis and Haemostasis · 2025
DOI: 10.1016/j.jtha.2024.09.022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von James Curtis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, Prisma Health Medical Group-Midlands, Columbia, South Carolina, USA. Hauptthemen laut MEDLINE: Anticoagulants, Platelet Aggregation Inhibitors, Fibrinolytic Agents, Thromboembolism. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 116 Literaturangaben.
Abstract (Originalsprache)
A growing number of patients receiving antithrombotic therapy require dental procedures. Dental interventions in these patients can be challenging, as the risk of bleeding from the continuation of antithrombotic therapy needs to be weighed against the thromboembolic risk associated with drug interruption or de-escalation. Most minor dental procedures, including simple dental cleaning and filling, pose minimal bleeding risk, and antiplatelet or anticoagulation therapy can be continued without interruption. Local hemostatic measures, such as tranexamic mouthwash, can be used, as needed, to reduce bleeding events following these interventions. Managing antithrombotic therapy during more invasive dental interventions and oral surgeries with a higher risk of perioperative bleeding necessitates the consideration of specific factors influencing the bleeding risk and thromboembolism. In patients receiving antithrombotic therapy for primary prevention, temporary interruption is reasonable. In others, the decisions may be more complex and more nuanced. In this article, we review the current evidence for managing patients receiving oral antiplatelet or anticoagulant drugs scheduled for various dental procedures and present a practical approach for the periprocedural management of antithrombotic treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dentistry, Prisma Health Medical Group-Midlands, Columbia, South Carolina, USA.
- Department of Pharmacy, Anticoagulation Management Service, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Pharmacy, Atrial Fibrillation Medication Management Clinic, Bri…
- Jamaica Hospital Medical Center, Queens, NY 11418, USA; Department of Medicine, Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Medicine, Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Medicine, Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School…
Zitieren
APA
Curtis, J., Henderson, D. P., Zarghami, M., Rashedi, S., & Bikdeli, B. (2025). Management of antithrombotic therapy in patients undergoing dental procedures. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.09.022
Vancouver
Curtis J, Henderson DP, Zarghami M, Rashedi S, Bikdeli B. Management of antithrombotic therapy in patients undergoing dental procedures. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2024.09.022
BibTeX
@article{Curtis2025,
author = {Curtis, James and Henderson, Daniel P and Zarghami, Mehrdad and Rashedi, Sina and Bikdeli, Behnood},
title = {Management of antithrombotic therapy in patients undergoing dental procedures},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
doi = {10.1016/j.jtha.2024.09.022}
}
EUVIMED